Developmental toxicity evaluation of gallium nitrate in mice

Area of Science:

• Toxicology
• Developmental Biology
• Pharmacology

Background:

• Gallium nitrate is an investigational antitumor agent.
• Limited animal toxicity data exists for this drug.
• Developmental toxicity data is crucial for assessing safety.

Purpose of the Study:

• To investigate the potential adverse developmental effects of gallium nitrate in pregnant mice.
• To determine the maternal and developmental toxicity profile of gallium nitrate.

Main Methods:

• Pregnant Swiss mice received intraperitoneal gallium nitrate at doses of 12.5, 25, 50, and 100 mg/kg/day during critical gestation periods.
• Maternal toxicity was assessed via body weight, food consumption, and clinical signs.
• Fetal development was evaluated by examining implant numbers, fetal weight, external/internal malformations, and skeletal variations.

Main Results:

• Maternal toxicity was observed across all treated groups.
• Embryo/fetal toxicity included reduced viable implants, decreased fetal weight, and increased skeletal variations at all tested doses.
• No significant increase in malformations occurred at doses up to 50 mg/kg.

Conclusions:

• Gallium nitrate exhibits both maternal and developmental toxicity in mice.
• The no-observable-adverse-effect level (NOAEL) for gallium nitrate was determined to be less than 12.5 mg/kg.
• Further studies are needed to fully characterize the developmental risks associated with gallium nitrate therapy.